Citation: A. Bornemann et Hh. Goebel, Introduction: Recent advances in hereditary neuromuscular diseases of childhood, BRAIN PATH, 11(2), 2001, pp. 190-192
Authors:
Goebel, HH
Halbig, LE
Goldfarb, L
Schober, R
Albani, M
Neuen-Jacob, E
Voit, T
Citation: Hh. Goebel et al., Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: Amixed congenital myopathy, NEUROPEDIAT, 32(4), 2001, pp. 196-205
Citation: N. Nardocci et Hh. Goebel, Neuronal ceroid lipofuscinoses - Current knowledge and perspectives - Introduction, NEUROL SCI, 21(3), 2000, pp. S13-S13
Authors:
Anderson, LVB
Harrison, RM
Pogue, R
Vafiadaki, E
Pollitt, C
Davison, K
Moss, JA
Keers, S
Pyle, A
Shaw, PJ
Mahjneh, I
Argov, Z
Greenberg, CR
Wrogemann, K
Bertorini, T
Goebel, HH
Beckmann, JS
Bashir, R
Bushby, KMD
Citation: Lvb. Anderson et al., Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies), NEUROMUSC D, 10(8), 2000, pp. 553-559
Authors:
Nowak, KJ
Wattanasirichaigoon, D
Goebel, HH
Wilce, M
Pelin, K
Donner, K
Jacob, RL
Hubner, C
Oexle, K
Anderson, JR
Verity, CM
North, KN
Iannaccone, ST
Muller, CR
Nurnberg, P
Muntoni, F
Sewry, C
Hughes, I
Sutphen, R
Lacson, AG
Swoboda, KJ
Vigneron, J
Wallgren-Pettersson, C
Beggs, AH
Laing, NG
Citation: Kj. Nowak et al., Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy, NAT GENET, 23(2), 1999, pp. 208-212
Authors:
Muller-Felber, W
Ansevin, CF
Ricker, K
Muller-Jenssen, A
Topfer, M
Goebel, HH
Pongratz, DE
Citation: W. Muller-felber et al., Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis, NEUROMUSC D, 9(8), 1999, pp. 604-607
Authors:
Hofman, I
Kohlschutter, A
Santavuori, P
Gottlob, I
Goebel, HH
Lake, BD
Schutgens, RBH
Greene, NDE
Leung, KY
Mitchison, HM
Munroe, PB
Taschner, PEM
Citation: I. Hofman et al., Juvenile NCL, BIOM HLTH R, 33, 1999, pp. 55-76